XOMA Royalty (XOMA) Interest Coverage Ratio (QoQ) (2011 - 2025)
XOMA Royalty (XOMA) Interest Coverage Ratio (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -68.38% |
| Mar 31, 2025 | 143.35% |
| Dec 31, 2024 | -176.34% |
| Sep 30, 2024 | -30.28% |
| Jun 30, 2024 | 67.96% |
| Mar 31, 2024 | 96.15% |
| Dec 31, 2023 | -5,556.99% |
| Sep 30, 2023 | -63.32% |
| Jun 30, 2023 | 95.40% |
| Mar 31, 2023 | 90.69% |
| Dec 31, 2022 | -28,542.00% |
| Sep 30, 2022 | -43.12% |
| Jun 30, 2022 | 99.28% |
| Mar 31, 2022 | -106.66% |
| Dec 31, 2021 | 372,046.01% |
| Sep 30, 2021 | -80.12% |
| Jun 30, 2021 | 99.58% |
| Mar 31, 2021 | -104.47% |
| Dec 31, 2020 | 275,011.22% |
| Sep 30, 2020 | 6.68% |